Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing this Study
1.3 Scope of Report
1.4 Information Sources
1.5 Methodology
1.6 Geographic Breakdown
1.7 Analyst's Credentials
1.8 Custom Research
1.9 Related Research Reports
Chapter 3 Technology Background
3.1 Introduction
3.1.1 History of Vaccine Development
3.1.2 Types of Vaccines
3.1.3 Attenuated (Live) Vaccines
3.1.4 Inactivated (Killed) Vaccines
3.1.5 Toxoid Vaccines
3.1.6 Subunit Vaccines
3.1.7 Conjugate Vaccines
3.1.8 Recombinant Vector Vaccines
3.1.9 Dna Vaccines
3.1.10 Rna Vaccines
3.1.11 Childhood Vaccination Policies
3.1.12 Pediatric Immunization
3.2 Regulatory Aspects
3.2.1 New Product Approvals
Chapter 4 Market Dynamics
4.1 Factors Affecting the Pediatric Vaccine Market
4.2 Market Drivers
4.2.1 Increasing Awareness and Government Support
4.2.2 Growing Investments and R&D
4.2.3 Product Approvals and Launches
4.2.4 Collaboration Agreements
4.2.5 Increasing Burden of Diseases
4.3 Market Restraints
4.3.1 Investment and Pricing
4.4 Market Opportunities
4.4.1 Increased Demand from Emerging Markets
Chapter 5 Impact of Covid-19 Pandemic
5.1 Introduction
5.2 Epidemiology
5.3 Impact of Covid-19 on the Pediatric Vaccine Market
Chapter 6 Pediatric Vaccine Market, by Technology
6.1 Global Market for Pediatric Vaccines, by Technology
6.2 Live Attenuated Vaccines
6.3 Inactivated Vaccines
6.4 Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
6.5 Toxoid Vaccines
6.6 Other/Combination Vaccines
Chapter 7 Pediatric Vaccine Market, by Disease Type
7.1 Pneumococcal
7.2 Diphtheria, Tetanus and Pertussis
7.3 Mmrv
7.4 Hpv
7.5 Influenza
7.6 Other Diseases
Chapter 8 Pediatric Vaccine Market, by Region
8.1 Global Market for Pediatric Vaccines, by Region
8.2 North America
8.2.1 United States
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 United Kingdom
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia-Pacific
8.5 Rest of the World
Chapter 9 New Developments
9.1 Phase I Clinical Trials
9.2 Phase II Clinical Trials
9.3 Phase III Clinical Trials
Chapter 10 Competitive Landscape
10.1 Market Shares of Pediatric Vaccine Companies
10.2 Strategic Initiatives
Chapter 11 Company Profiles
- Abbott Laboratories
- Astrazeneca plc
- Bharat Biotech International Ltd.
- Csl Seqirus UK Ltd.
- Emergent Biosolutions Inc.
- GlaxoSmithKline
- Merck & Co, Inc.
- Panacea Biotec Ltd.
- Pfizer Inc.
- Sanofi S.A.
- Serum Institute of India Ltd.
- Sinovac Biotech Ltd.
List of Tables
Summary Table B: Global Market for Pediatric Vaccines, by Region, Through 2027
Summary Table A: Global Market for Pediatric Vaccines, Through 2027
Table 1: Pros and Cons of Attenuated (Live) Vaccines
Table 2: Pros and Cons of Inactivated (Killed) Vaccines
Table 3: Pros and Cons of Toxoid Vaccines
Table 4: Pros and Cons of Subunit Vaccines
Table 5: Pros and Cons of Conjugate Vaccines
Table 6: Pros and Cons of Recombinant Vector Vaccines
Table 7: Pros and Cons, DNA Vaccines
Table 8: Pros and Cons of RNA Vaccines
Table 9: Recommended Vaccinations for Infants and Children (Birth through 6 Years) in the U.S, 2022
Table 10: Recommended Vaccinations for Children Age 7-18, in the U.S., 2022
Table 11: Pediatric/VFC Vaccine Price List, 2022
Table 12: Pediatric Influenza Vaccine Price List, 2022
Table 13: Newly Approved Pediatric Vaccines, January 2019-July 2022
Table 14: COVID-19 Confirmed Cases and Deaths, by WHO Region, as of August 3, 2022
Table 15: Global Market for Pediatric Vaccines, Through 2027
Table 16: Global Market for Pediatric Vaccines, by Technology, Through 2027
Table 17: Global Market for Live Attenuated Pediatric Vaccines, by Region, Through 2027
Table 18: Global Market for Inactivated Pediatric Vaccines, by Region, Through 2027
Table 19: Global Market for Subunit, Recombinant, Polysaccharide and Conjugate Pediatric Vaccines, by Region, Through 2027
Table 20: Global Market for Toxoid Pediatric Vaccines, by Region, Through 2027
Table 21: Global Market for Other and Combination Pediatric Vaccines, by Region, Through 2027
Table 22: Global Market for Pediatric Vaccines, by Disease Type, Through 2027
Table 23: Global Market for Pneumococcal Pediatric Vaccines, by Region, Through 2027
Table 24: Global Market for Diphtheria, Tetanus and Pertussis Pediatric Vaccines, by Region, Through 2027
Table 25: Global Market for MMRV Pediatric Vaccines, by Region, Through 2027
Table 26: Global Market for HPV Pediatric Vaccines, by Region, Through 2027
Table 27: Global Market for Influenza Pediatric Vaccines, by Region, Through 2027
Table 28: Global Market for Pediatric Vaccines for Other Diseases, by Region, Through 2027
Table 29: Global Market for Pediatric Vaccines, by Region, Through 2027
Table 30: North American Market for Pediatric Vaccines, by Country, Through 2027
Table 31: European Market for Pediatric Vaccines, by Country, Through 2027
Table 32: Asia-Pacific Market for Pediatric Vaccines, by Country, Through 2027
Table 33: Pediatric Vaccines in Phase I Clinical Trials
Table 34: Pediatric Vaccines in Phase II Clinical Trials
Table 35: Vaccines in Phase III and Registration Clinical Trials
Table 36: Pfizer: Financial Performance, 2019-2021
List of Figures
Summary Figure A: Global Market for Pediatric Vaccines, 2020-2027
Summary Figure B: Global Market for Pediatric Vaccines, by Region, 2020-2027
Figure 1: Global Vaccination Coverage, by Vaccine, 2021
Figure 2: Vaccine Timeline, Since 1800s
Figure 3: Number of Countries with Childhood Vaccination Policies, by Vaccination Classification, 2021
Figure 4: Global Market for Pediatric Vaccines, by Technology, 2020-2027
Figure 5: Global Market Share for Pediatric Vaccines, by Technology, 2021
Figure 6: Global Market for Live-Attenuated Pediatric Vaccines, by Region, 2020-2027
Figure 7: Global Market for Inactivated Pediatric Vaccines, by Region, 2020-2027
Figure 8: Global Market for Subunit, Recombinant, Polysaccharide and Conjugate Pediatric Vaccines, by Region, 2020-2027
Figure 9: Global Market for Toxoid Pediatric Vaccines, by Region, 2020-2027
Figure 10: Global Market for Other and Combination Pediatric Vaccines, by Region, 2020-2027
Figure 11: Global Market for Pediatric Vaccines, by Disease Type, 2020-2027
Figure 12: Global Market Share for Pediatric Vaccines, by Disease Type, 2021
Figure 13: Global Market for Pneumococcal Pediatric Vaccines, by Region, 2020-2027
Figure 14: Global Market for Diphtheria, Tetanus and Pertussis Pediatric Vaccines, by Region, 2020-2027
Figure 15: Global Market for MMRV Pediatric Vaccines, by Region, 2020-2027
Figure 16: Countries with HPV Vaccine in the National Immunization Schedule, by Income Group, 2020
Figure 17: Global Market for HPV Pediatric Vaccines, by Region, 2020-2027
Figure 18: Global Market for Influenza Pediatric Vaccines, by Region, 2020-2027
Figure 19: Global Market for Pediatric Vaccines for Other Diseases, by Region, 2020-2027
Figure 20: Global Market for Pediatric Vaccines, by Region, 2020-2027
Figure 21: Shares of Global Market for Pediatric Vaccines, by Region, 2021
Figure 22: North American Market for Pediatric Vaccines, by Country, 2020-2027
Figure 23: U.S. Market for Pediatric Vaccines, 2020-2027
Figure 24: Canadian Market for Pediatric Vaccines, 2020-2027
Figure 25: European Market for Pediatric Vaccines, by Country, 2020-2027
Figure 26: German Market for Pediatric Vaccines, 2020-2027
Figure 27: U.K. Market for Pediatric Vaccines, 2020-2027
Figure 28: French Market for Pediatric Vaccines, 2020-2027
Figure 29: Italian Market for Pediatric Vaccines, 2020-2027
Figure 30: Spanish Market for Pediatric Vaccines, 2020-2027
Figure 31: Rest of Europe Market for Pediatric Vaccines, 2020-2027
Figure 32: Asia-Pacific Market for Pediatric Vaccines, by Country, 2020-2027
Figure 33: Chinese Market for Pediatric Vaccines, 2020-2027
Figure 34: Japanese Market for Pediatric Vaccines, 2020-2027
Figure 35: Indian Market for Pediatric Vaccines, 2020-2027
Figure 36: Rest of Asia-Pacific Market for Pediatric Vaccines, 2020-2027
Figure 37: RoW Market for Pediatric Vaccines, 2020-2027
Figure 38: Shares of Global Market for Pediatric Vaccines, by Company, 2021
Figure 39: Abbott Laboratories: Net Revenue, 2019-2021
Figure 40: Abbott Laboratories: Revenue Share, by Business Segment, 2021
Figure 41: Abbott Laboratories: Revenue Share, by Country, 2021
Figure 42: AstraZeneca: Net Revenue, 2019-2021
Figure 43: AstraZeneca: Revenue Share, by Business Segment, 2021
Figure 44: AstraZeneca: Revenue Share, by Region, 2021
Figure 45: CSL Ltd. (Seqirus): Net Revenue, 2019-2021
Figure 46: CSL Ltd. (Seqirus): Revenue Share, by Business Segment, 2021
Figure 47: Emergent BioSolutions: Net Revenue, 2019-2021
Figure 48: GlaxoSmithKline: Net Revenue, 2019-2021
Figure 49: GlaxoSmithKline: Revenue Share, by Business Segment, 2021
Figure 50: GlaxoSmithKline: Revenue Share, by Region, 2021
Figure 51: Merck & Co.: Annual Revenue, 2019-2021
Figure 52: Merck & Co.: Revenue Share, by Business Segment, 2021
Figure 53: Merck & Co.: Revenue Share, by Region, 2021
Figure 54: Pfizer: Annual Revenue, 2019-2021
Figure 55: Pfizer: Net Sales Share, by Business Segment, 2021
Figure 56: Pfizer: Net Sales Share, by Region, 2021
Figure 57: Sanofi SA: Net Revenue, 2019-2021
Figure 58: Sanofi SA: Revenue Share, by Business Segment, 2021
Figure 59: Sanofi SA: Revenue Share, by Region, 2021
